GLP-1 RAs appear safe and effective in dialysis patients with type 2 diabetes, according to this real-world analysis. The mortality benefit is substantial and clinically meaningful.| MedicalResearch.com | ID Week 2025: Shingrix Vaccine for Shingles Associated ...